Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biologics and related products (such as vaccines, live biotherapeutics (probiotics), blood products, and cell, tissue, and gene therapies). Not all biologics are regulated by CBER. Monoclonal antibodies and other therapeutic proteins are regulated by the FDA Center for Drug Evaluation and Research (CDER).
child organisation
Wikipage disambiguates
BioCompute ObjectBiologics Control ActBiologics license applicationBiopharmaceuticalBreakthrough therapyBureau of BiologicsCBERCBER (disambiguation)Catharine Mans BosioCenter for Drug Evaluation and ResearchCenter for biologics evaluation and researchContract manufacturing organizationCutter LaboratoriesCytelDaniel R. LuceyDermatologic and Ophthalmic Drugs Advisory CommitteeEdwin D. KilbourneEmergency Use AuthorizationFDA Adverse Event Reporting SystemFDA warning letterFecal microbiota transplantFood and Drug AdministrationFood and Drug Administration Safety and Innovation ActGiovanna TosatoGood clinical data management practiceGood tissue practiceInfluenza researchJanet WoodcockJim (horse)Kathryn ZoonLuciana BorioMenAfriVacOffice of Blood Research and ReviewOncology Drug Advisory CommitteeOutline of clinical researchPeanut allergyPeter Marks (physician)Prescription Drug User Fee ActRegulation of scienceRonald J. Falk
Link from a Wikipage to another Wikipage
child1 agency
primaryTopic
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biologics and related products (such as vaccines, live biotherapeutics (probiotics), blood products, and cell, tissue, and gene therapies). Not all biologics are regulated by CBER. Monoclonal antibodies and other therapeutic proteins are regulated by the FDA Center for Drug Evaluation and Research (CDER).
has abstract
The Center for Biologics Evalu ...... valuation and Research (CDER).
@en
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
1,008,688,984
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
subject
hypernym
sameAs
comment
The Center for Biologics Evalu ...... valuation and Research (CDER).
@en
label
Center for Biologics Evaluation and Research
@en